These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15215221)

  • 1. Effect of inoculum density on susceptibility of Plesiomonas shigelloides to cephalosporins.
    Wiegand I; Burak S
    J Antimicrob Chemother; 2004 Aug; 54(2):418-23. PubMed ID: 15215221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium.
    Stock I; Wiedemann B
    Scand J Infect Dis; 2001; 33(9):692-6. PubMed ID: 11669228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula.
    Maglio D; Ong C; Banevicius MA; Geng Q; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1941-7. PubMed ID: 15155182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
    Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW
    J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-lactamase expression in Plesiomonas shigelloides.
    Avison MB; Bennett PM; Walsh TR
    J Antimicrob Chemother; 2000 Jun; 45(6):877-80. PubMed ID: 10837443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural antimicrobial susceptibilities of Plesiomonas shigelloides strains.
    Stock I; Wiedemann B
    J Antimicrob Chemother; 2001 Dec; 48(6):803-11. PubMed ID: 11733464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
    Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
    J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity, beta-lactamase stability and PBP affinity of RU 51,746-2, the active metabolite of the new orally absorbed cephalosporin ester, RU 51807.
    Boaretti M; Lleó MM; Canepari P
    J Chemother; 1991 Jan; 3 Suppl 1():57-61. PubMed ID: 12041787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
    Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
    J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan.
    Muratani T; Kobayashi T; Matsumoto T
    Int J Antimicrob Agents; 2006 Jun; 27(6):491-9. PubMed ID: 16701983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
    Koh TH; Wang G; Koh TY
    Int J Antimicrob Agents; 2008 Apr; 31(4):382-3. PubMed ID: 18178066
    [No Abstract]   [Full Text] [Related]  

  • 16. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
    J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases and strains with extended-spectrum activity of the chromosomal beta-lactamase.
    Decré D; Burghoffer B; Gautier V; Petit JC; Arlet G
    J Antimicrob Chemother; 2004 Nov; 54(5):881-8. PubMed ID: 15472005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antimicrobial sensitivity and plasmid isolation in Plesiomonas shigelloides].
    Bravo Fariñas L; de Paula Almeida OS; Maestre Mesa J; Ramírez Alvarez M; García Rodríguez B
    Rev Cubana Med Trop; 1998; 50(3):203-6. PubMed ID: 10349444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.